Uremia alters HDL composition and function

Michael Holzer, Ruth Birner-Gruenberger, Tatjana Stojakovic, Dalia El-Gamal, Veronika Binder, Christian Wadsack, Akos Heinemann, Gunther Marsche

Research output: Contribution to journalArticle

172 Citations (Scopus)

Abstract

Functional impairment of HDL may contribute to the excess cardiovascular mortality experienced by patients with renal disease but the effect of advanced renal disease on the composition and function of HDL is not well understood. Here we used mass spectrometry and biochemical analyses to study alterations in the proteome and lipid composition of HDL isolated from patients on maintenance hemodialysis. We identified a significant increase in the amount of acute phase protein serum amyloid A1 albumin lipoprotein-associated phospholipase A2 and apoC-III composing uremic HDL. Furthermore uremic HDL contained reduced phospholipid and increased triglyceride and lysophospholipid. With regard to function these changes impaired the ability of uremic HDL to promote cholesterol efflux from macrophages. In summary the altered composition of HDL in renal disease seems to inhibit its cardioprotective properties. Assessing HDL composition and function in renal disease may help identify patients at increased risk for cardiovascular disease.

Original languageEnglish (US)
Pages (from-to)1631-1641
Number of pages11
JournalJournal of the American Society of Nephrology
Volume22
Issue number9
DOIs
StatePublished - Sep 1 2011

Fingerprint

Uremia
Kidney
Group III Phospholipases A2
1-Alkyl-2-acetylglycerophosphocholine Esterase
Apolipoprotein C-III
Lysophospholipids
Acute-Phase Proteins
Proteome
Amyloid
Renal Dialysis
Albumins
Mass Spectrometry
Phospholipids
Triglycerides
Cardiovascular Diseases
Macrophages
Cholesterol
Maintenance
Lipids
Mortality

ASJC Scopus subject areas

  • Nephrology

Cite this

Holzer, M., Birner-Gruenberger, R., Stojakovic, T., El-Gamal, D., Binder, V., Wadsack, C., ... Marsche, G. (2011). Uremia alters HDL composition and function. Journal of the American Society of Nephrology, 22(9), 1631-1641. https://doi.org/10.1681/ASN.2010111144

Uremia alters HDL composition and function. / Holzer, Michael; Birner-Gruenberger, Ruth; Stojakovic, Tatjana; El-Gamal, Dalia; Binder, Veronika; Wadsack, Christian; Heinemann, Akos; Marsche, Gunther.

In: Journal of the American Society of Nephrology, Vol. 22, No. 9, 01.09.2011, p. 1631-1641.

Research output: Contribution to journalArticle

Holzer, M, Birner-Gruenberger, R, Stojakovic, T, El-Gamal, D, Binder, V, Wadsack, C, Heinemann, A & Marsche, G 2011, 'Uremia alters HDL composition and function', Journal of the American Society of Nephrology, vol. 22, no. 9, pp. 1631-1641. https://doi.org/10.1681/ASN.2010111144
Holzer M, Birner-Gruenberger R, Stojakovic T, El-Gamal D, Binder V, Wadsack C et al. Uremia alters HDL composition and function. Journal of the American Society of Nephrology. 2011 Sep 1;22(9):1631-1641. https://doi.org/10.1681/ASN.2010111144
Holzer, Michael ; Birner-Gruenberger, Ruth ; Stojakovic, Tatjana ; El-Gamal, Dalia ; Binder, Veronika ; Wadsack, Christian ; Heinemann, Akos ; Marsche, Gunther. / Uremia alters HDL composition and function. In: Journal of the American Society of Nephrology. 2011 ; Vol. 22, No. 9. pp. 1631-1641.
@article{790bbcc7fc284b428bb133a366381030,
title = "Uremia alters HDL composition and function",
abstract = "Functional impairment of HDL may contribute to the excess cardiovascular mortality experienced by patients with renal disease but the effect of advanced renal disease on the composition and function of HDL is not well understood. Here we used mass spectrometry and biochemical analyses to study alterations in the proteome and lipid composition of HDL isolated from patients on maintenance hemodialysis. We identified a significant increase in the amount of acute phase protein serum amyloid A1 albumin lipoprotein-associated phospholipase A2 and apoC-III composing uremic HDL. Furthermore uremic HDL contained reduced phospholipid and increased triglyceride and lysophospholipid. With regard to function these changes impaired the ability of uremic HDL to promote cholesterol efflux from macrophages. In summary the altered composition of HDL in renal disease seems to inhibit its cardioprotective properties. Assessing HDL composition and function in renal disease may help identify patients at increased risk for cardiovascular disease.",
author = "Michael Holzer and Ruth Birner-Gruenberger and Tatjana Stojakovic and Dalia El-Gamal and Veronika Binder and Christian Wadsack and Akos Heinemann and Gunther Marsche",
year = "2011",
month = "9",
day = "1",
doi = "10.1681/ASN.2010111144",
language = "English (US)",
volume = "22",
pages = "1631--1641",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "9",

}

TY - JOUR

T1 - Uremia alters HDL composition and function

AU - Holzer, Michael

AU - Birner-Gruenberger, Ruth

AU - Stojakovic, Tatjana

AU - El-Gamal, Dalia

AU - Binder, Veronika

AU - Wadsack, Christian

AU - Heinemann, Akos

AU - Marsche, Gunther

PY - 2011/9/1

Y1 - 2011/9/1

N2 - Functional impairment of HDL may contribute to the excess cardiovascular mortality experienced by patients with renal disease but the effect of advanced renal disease on the composition and function of HDL is not well understood. Here we used mass spectrometry and biochemical analyses to study alterations in the proteome and lipid composition of HDL isolated from patients on maintenance hemodialysis. We identified a significant increase in the amount of acute phase protein serum amyloid A1 albumin lipoprotein-associated phospholipase A2 and apoC-III composing uremic HDL. Furthermore uremic HDL contained reduced phospholipid and increased triglyceride and lysophospholipid. With regard to function these changes impaired the ability of uremic HDL to promote cholesterol efflux from macrophages. In summary the altered composition of HDL in renal disease seems to inhibit its cardioprotective properties. Assessing HDL composition and function in renal disease may help identify patients at increased risk for cardiovascular disease.

AB - Functional impairment of HDL may contribute to the excess cardiovascular mortality experienced by patients with renal disease but the effect of advanced renal disease on the composition and function of HDL is not well understood. Here we used mass spectrometry and biochemical analyses to study alterations in the proteome and lipid composition of HDL isolated from patients on maintenance hemodialysis. We identified a significant increase in the amount of acute phase protein serum amyloid A1 albumin lipoprotein-associated phospholipase A2 and apoC-III composing uremic HDL. Furthermore uremic HDL contained reduced phospholipid and increased triglyceride and lysophospholipid. With regard to function these changes impaired the ability of uremic HDL to promote cholesterol efflux from macrophages. In summary the altered composition of HDL in renal disease seems to inhibit its cardioprotective properties. Assessing HDL composition and function in renal disease may help identify patients at increased risk for cardiovascular disease.

UR - http://www.scopus.com/inward/record.url?scp=80052336462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052336462&partnerID=8YFLogxK

U2 - 10.1681/ASN.2010111144

DO - 10.1681/ASN.2010111144

M3 - Article

C2 - 21804091

AN - SCOPUS:80052336462

VL - 22

SP - 1631

EP - 1641

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 9

ER -